SIGA Technologies Inc.
Ticker(s):
SIGA
Country:
Sector & Industry:
Business Overview
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. The company’s lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Contact & Other Information
Number of Employees:
46
Website:
31 East 62nd Street
New York
,
NY
,
10065
United States
212 672 9100
No content was found.